AlphaYouSK
Insider selling
Suma Krishnan sold $9M of Krystal Biotech, Inc. (KRYS) stock
Suma Krishnan, President, R&D, 10% of Krystal Biotech, Inc. (KRYS), sold 25,000 shares of KRYS stock worth $9M, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 4, 2026.
KRYS has moved -7.4% since the trade date, from $358.24 to $331.61 (Oct 9, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 0 days
- Price since
- -7.4%
- Role
- President, R&D, 10%
- Source
- SEC Form 4
More KRYS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.